Nurse Practitioner, Family · Staten Island, NY
NPI
1942780390
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
3350 Victory Blvd
Staten Island, NY, 10314
Phone (347) 672-0805
Groups this clinician bills Medicare through
Medicare paid, 2022
$132K
2,335 services
Medicare patients, 2022
560
Average age 79
Drug cost, 2024
$4.2M
9,518 prescriptions
Company payments, 2025
$475
From 9 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Natallia Kleshchanka was code 99308 (snf e&m), 1,520 times for 399 patients. In total Natallia Kleshchanka billed 2,335 services in 11 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 1,520 | 399 | $51.37 | $78K |
| 99309 SNF E&M | Facility | 212 | 90 | $69.71 | $15K |
| 99305 SNF E&M | Facility | 169 | 162 | $96.18 | $16K |
| 99308 SNF E&M | Office | 109 | 34 | $50.62 | $5,517 |
| 11042 Debridement | Facility | 90 | 48 | $48.84 | $4,396 |
| 99304 SNF E&M | Facility | 47 | 47 | $64.09 | $3,012 |
| 99305 SNF E&M | Office | 42 | 42 | $89.43 | $3,756 |
| 99307 SNF E&M | Facility | 36 | 34 | $30.50 | $1,098 |
Medicare prescription drug claims, 2024
In 2024, the drug Natallia Kleshchanka prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 989 prescriptions and refills. In total Natallia Kleshchanka wrote 9,518 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 989 | 1,053 | 229 | $1.1M |
| Trulicity Dulaglutide | 843 | 964 | 191 | $903K |
| Atorvastatin Calcium Generic | 710 | 953 | 201 | $3,196 |
| Jardiance Empagliflozin | 578 | 658 | 141 | $379K |
| Metformin Hcl Generic | 533 | 637 | 140 | $15K |
| Ozempic Semaglutide | 424 | 477 | 113 | $439K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 385 | 461 | 102 | $258K |
| Levothyroxine Sodium Generic | 338 | 454 | 93 | $1,740 |
| Rosuvastatin Calcium Generic | 272 | 335 | 83 | $2,654 |
| Synthroid Levothyroxine Sodium | 203 | 271 | 50 | $10K |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 188 | 250 | 64 | $3,660 |
| Glimepiride Generic | 167 | 209 | 44 | $798 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 160 | 228 | 46 | $38K |
| Losartan Potassium Generic | 158 | 248 | 52 | $875 |
| Metformin Hcl Er Metformin Hcl | 156 | 225 | 49 | $2,245 |
Brand drugs: 4,998 claims; generic drugs: 3,703 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natallia Kleshchanka $475 ($475 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $148.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $148 |
| Astellas Pharma US Inc 4503.T | 3 | $123 |
| Lilly USA, LLC LLY | 3 | $58.22 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $47.27 |
| Insulet Corporation PODD | 1 | $24.37 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $23.94 |
| Xeris Pharmaceuticals, Inc. | 1 | $20.03 |
| Antares Pharma, Inc. | 1 | $16.64 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $13.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.